TITAN: Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV

10-1074 - National Institute of Allergy and Infectious Diseases, Rockefeller University, Gilead

3BNC117 - Rockefeller University, Cornell University, Frontier Biotech, Gilead

lefitolimod (MGN1703) - OncXerna Therap, iPharma, Gilead

TITAN: Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV (clinicaltrials.gov) - May 23, 2023 - P2a | N=47 | Completed | Sponsor: University of Aarhus | Active, not recruiting ➔ Completed
Trial completion • Human Immunodeficiency Virus • Infectious Disease • CD4

http://clinicaltrials.gov/ct2/show/NCT03837756

May 23, 2023